Trevor J. Hallam
Equibles does not estimate personal net worth.
About Trevor J. Hallam
Sutro Biopharma, Inc. reported in an 8-K filed April 27, 2023 that Trevor J. Hallam resigned as President of Research and Chief Scientific Officer, effective May 31, 2023. The proxy statement of Sutro Biopharma, Inc. reports total compensation of $1,031,080 for Trevor J. Hallam in fiscal 2019, including a base salary of $418,000. Disclosed compensation is on record for 2 fiscal years.
“On April 24, 2023, Dr. Trevor Hallam notified Sutro Biopharma, Inc. (the "Company") that he will resign from his role as President of Research and Chief Scientific Officer of the Company, effective May 31, 2023.”
Affiliation history
-
Sutro Biopharma, Inc. (STRO)
Proxy statement
Start not stated–2023-05-31
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Sutro Biopharma, Inc. (STRO) | Chief Scientific Officer | $418,000 | $1,031,080 |
| 2018 | Sutro Biopharma, Inc. (STRO) | Chief Scientific Officer | $405,800 | $4,395,163 |